NextCure, Inc.
NXTC
$0.3612
$0.02647.89%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -55.65M | -58.52M | -61.28M | -63.73M | -62.72M |
| Total Depreciation and Amortization | 2.87M | 3.02M | 3.26M | 3.51M | 3.68M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 7.45M | 7.88M | 8.38M | 9.02M | 8.01M |
| Change in Net Operating Assets | 4.53M | 3.11M | 3.81M | 398.00K | -1.94M |
| Cash from Operations | -40.81M | -44.51M | -45.83M | -50.80M | -52.97M |
| Capital Expenditure | -474.00K | -521.00K | -630.00K | -609.00K | -820.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 55.78M | 53.03M | 45.11M | 39.64M | 40.09M |
| Cash from Investing | 55.31M | 52.51M | 44.48M | 39.03M | 39.27M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 144.00K | 179.00K | 178.00K | 155.00K | 154.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 144.00K | 179.00K | 178.00K | 155.00K | 154.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 14.65M | 8.18M | -1.17M | -11.62M | -13.55M |